Telehealth has greatly increased patient engagement during the pandemic while AI and remote patient monitoring can increase the chances of detecting diseases or conditions early with real-time monitoring.
Lunit's INSIGHT MMG, an AI tool for breast cancer screening, matches human radiologists' accuracy, revolutionizing diagnostics and prompting integration into standard protocols.
Neurovalens successfully secured 510(k) clearance from the FDA on October 27, 2023 for its Modius Sleep device with relation to treatment of insomnia and/or anxiety. The clearance was.